Abstract
Influenza is a major cause of morbidity for people with significant underlying disease, but the impact of influenza on people infected with human immunodeficiency virus (HIV) remains unclear. We studied a population of HIV-infected adults during the 1998-1999 influenza season to see whether influenza had any adverse effects on the course of HIV infection. During 5 months of follow-up, we found no unique clinical manifestations or negative impact on CD4(+) cell count, virus load, or clinical progression of HIV disease. Although half of our cohort received antibiotic therapy, none received specific anti-influenza therapy and none required hospitalization. Acute influenza does not appear to be a risk for progression of HIV disease.
MeSH terms
-
AIDS-Related Opportunistic Infections / drug therapy
-
AIDS-Related Opportunistic Infections / epidemiology
-
AIDS-Related Opportunistic Infections / physiopathology*
-
AIDS-Related Opportunistic Infections / prevention & control
-
Acute Disease
-
Adult
-
Anti-HIV Agents / therapeutic use
-
CD4 Lymphocyte Count
-
Dideoxynucleosides / therapeutic use
-
Disease Outbreaks*
-
Disease Progression
-
Female
-
Humans
-
Influenza Vaccines
-
Influenza, Human / drug therapy
-
Influenza, Human / epidemiology
-
Influenza, Human / physiopathology*
-
Influenza, Human / prevention & control
-
Male
-
Middle Aged
-
Reverse Transcriptase Inhibitors / therapeutic use
Substances
-
Anti-HIV Agents
-
Dideoxynucleosides
-
Influenza Vaccines
-
Reverse Transcriptase Inhibitors
-
abacavir